Target intelligence / Profile preview

Sodium-dependent vitamin C transporter 1 and 2 (SVCT1 and SVCT2) (SVCT1 and SVCT2)

Target
SVCT1 and SVCT2
Molecular classification
Transporter, Solute carrier family
01

Overview

Sodium-dependent vitamin C transporters 1 and 2 (SVCT1 and SVCT2) are specialized transmembrane proteins responsible for the uptake of L-ascorbic acid (vitamin C) into cells (Bürzle et al., 2011). SVCT1, encoded by the SLC23A1 gene, is primarily expressed in epithelial tissues such as the small intestine and proximal renal tubules, where it regulates systemic vitamin C homeostasis through absorption and reabsorption (UniProt Consortium, 2024). In contrast, SVCT2, encoded by SLC23A2, is ubiquitously expressed with high levels in the brain, neuroendocrine tissues, and the eye, serving to maintain high intracellular ascorbate concentrations required for antioxidant protection and enzymatic co-factor functions (Nualart et al., 2014). These transporters utilize a sodium-gradient-driven symport mechanism to move ascorbate against its concentration gradient (Savini et al., 2008). In clinical contexts, SVCT2 is often overexpressed in various cancer types to mitigate oxidative stress, making it a potential target for redox-based therapies (Sotiriou et al., 2002). Conversely, mutations or downregulation of these transporters are linked to increased susceptibility to chronic diseases, including cardiovascular and neurodegenerative disorders, due to impaired antioxidant capacity (May, 2011).

Other names
SLC23A1SLC23A2Solute carrier family 23 member 1Solute carrier family 23 member 2hSVCT1hSVCT2Yolk sac permease-like protein 1Yolk sac permease-like protein 2
02

Mechanism of action

Sodium-coupled active transport of L-ascorbic acid across the plasma membrane against a concentration gradient

03

Biological functions

Vitamin C transportAntioxidant homeostasisCollagen biosynthesisCatecholamine synthesisBone formationNeuroprotection
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseScurvyCataractDiabetes mellitus
05

Safety considerations

Genetic polymorphisms affecting vitamin C absorptionRisk of kidney stones with high-dose ascorbateOxidative stress vulnerability if transporters are inhibitedDrug-nutrient interactions affecting bioavailability
06

Interacting drugs

Ascorbic acid

4 more in the full profile.

07

Biomarkers

SLC23A1 mRNA expressionSLC23A2 mRNA expressionPlasma ascorbic acid levelsIntracellular ascorbate concentration

Beyond the preview

Go deeper on Sodium-dependent vitamin C transporter 1 and 2 (SVCT1 and SVCT2) (SVCT1 and SVCT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent vitamin C transporter 1 and 2 (SVCT1 and SVCT2) (SVCT1 and SVCT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call